Affinage

Showing GOLGA4GOLGIN-245 is a alias.

GOLGA4

Golgin subfamily A member 4 · UniProt Q13439

Length
2230 aa
Mass
261.1 kDa
Annotated
2026-06-10
34 papers in source corpus 12 papers cited in narrative 13 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

GOLGA4 (golgin-245/p230) is a peripheral membrane golgin that defines the cytosolic face of the trans-Golgi network (TGN) and links it to cargo export and cytoskeletal transport (PMID:9013329, PMID:15265687). It was first identified as a large coiled-coil Golgi autoantigen bearing a granin signature motif (PMID:8537393, PMID:8626529), and cycles reversibly between cytosol and TGN under G protein control, decorating a distinct population of non-clathrin-coated TGN-derived vesicles (PMID:9013329). Its C-terminal GRIP domain is necessary and sufficient for Golgi targeting through direct, brefeldin A-sensitive interaction with the GTP-bound Arl1 GTPase, which recruits the protein to TGN membranes (PMID:10318758, PMID:16413289). Its N-terminal domain binds the microtubule-actin crosslinking protein MACF1, and this interaction drives transport of GPI-anchored proteins—but not transmembrane cargo such as VSVG—from the TGN to the cell periphery (PMID:15265687). Through interaction with CD99 in the TGN, GOLGA4 also participates in trafficking of HLA class I molecules to the cell surface (PMID:18849489). The same GOLGA4-MACF1 axis is required for starvation-induced autophagy, mediating mAtg9 delivery from the TGN to peripheral phagophores (PMID:25436429). Super-resolution imaging positions GOLGA4 in a discrete layer at the Golgi rim, where golgins form anti-parallel dimers that self-assemble into filamentous bands consistent with a structural scaffolding role. Chromosomal rearrangements fuse GOLGA4 to kinase domains, generating GOLGA4-JAK2 and GOLGA4-RAF1 fusions that constitutively activate JAK/STAT and RAF-MEK-ERK signaling in B-cell ALL and melanoma respectively (PMID:34697799, PMID:30835257).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 1995 Medium

    Established the molecular identity of GOLGA4 as a large cytosolic Golgi protein, defining its coiled-coil architecture and granin signature before any function was known.

    Evidence cDNA cloning from a HeLa library using anti-Golgi autoimmune serum, with immunoprecipitation and sequence analysis

    PMID:8537393 PMID:8626529

    Open questions at the time
    • No functional role assigned at this stage
    • Sub-Golgi localization not yet resolved
    • Membrane-targeting determinant unknown
  2. 1996 High

    Resolved where GOLGA4 acts by placing it on the cytosolic face of the TGN on a distinct class of non-clathrin-coated budding vesicles, and showed its membrane association is G protein-regulated.

    Evidence Immunogold EM of HeLa cryosections, streptolysin-O permeabilization, and AlF4-/GTP-gamma-S treatment of isolated Golgi membranes

    PMID:9013329

    Open questions at the time
    • Identity of the regulatory G protein not determined
    • Vesicle cargo and destination unknown
    • Targeting domain not mapped
  3. 1999 High

    Mapped the membrane-targeting determinant to a minimal C-terminal region, showing this domain is necessary, sufficient, and competitive for Golgi binding under G protein control.

    Evidence GFP-tagged deletion and alanine-scanning mutants expressed in COS cells with fluorescence microscopy and competition assays

    PMID:10318758

    Open questions at the time
    • The membrane receptor binding this domain not yet identified
    • Mechanism of brefeldin A sensitivity unresolved
  4. 2004 High

    Connected GOLGA4 to cytoskeletal cargo transport by identifying a direct N-terminal interaction with MACF1 that is required specifically for GPI-anchored protein export from the TGN.

    Evidence Yeast two-hybrid, reciprocal co-IP, in vitro binding, and cargo-specific YFP-SP-GPI trafficking assay with dominant-negative constructs in HeLa cells

    PMID:15265687

    Open questions at the time
    • How cargo selectivity for GPI-anchored proteins is achieved is unclear
    • Coupling between GOLGA4 vesicles and the cytoskeletal motor machinery not defined
  5. 2005 Medium

    Identified the receptor for the C-terminal GRIP domain, showing GTP-bound Arl1 directly recruits GOLGA4 to the TGN, explaining the G protein-regulated targeting.

    Evidence Bidirectional GST pull-down recovering endogenous Golgin-245 with GST-Arl1(GTP) and endogenous active Arl1 with GST-GRIP

    PMID:16413289

    Open questions at the time
    • Pull-down only; no reconstitution or structural validation
    • Stoichiometry and regulation of the Arl1-GRIP interaction unresolved
  6. 2008 Medium

    Extended GOLGA4 function to immune cargo trafficking by demonstrating a CD99 interaction that controls HLA class I surface delivery from the TGN.

    Evidence Co-IP, IFN-gamma stimulation, dominant-negative GRIP overexpression, and flow cytometry for surface HLA class I

    PMID:18849489

    Open questions at the time
    • Whether CD99 is the direct cargo adaptor or a regulator is unclear
    • Single lab, dominant-negative readout only
  7. 2014 Medium

    Showed the GOLGA4-MACF1 axis serves autophagy, supplying mAtg9 from the TGN to peripheral phagophores during starvation-induced autophagosome biogenesis.

    Evidence siRNA knockdown of p230 and MACF1 in HeLa cells with LC3 puncta quantification, mAtg9 trafficking, autophagic flux, and dominant-negative MACF1

    PMID:25436429

    Open questions at the time
    • Whether GOLGA4 acts on phagophores directly or only at the TGN source is unresolved
    • Detection of GOLGA4 in autophagosomes not mechanistically explained
  8. 2020 Medium

    Tested physiological requirement in vivo, finding GOLGA4 dispensable for mouse spermatogenesis despite high testis expression, indicating functional redundancy at the organismal level.

    Evidence CRISPR/Cas9 global knockout mice with fertility testing, testicular histology, and sperm morphology analysis

    PMID:32736686

    Open questions at the time
    • Negative result does not address roles in other tissues
    • Possible compensation by other golgins not examined
  9. 2021 Medium

    Revealed an oncogenic role through chromosomal fusion, with GOLGA4-JAK2 driving constitutive JAK/STAT activation and factor-independent growth in B-cell precursors.

    Evidence mRNA-seq fusion detection, retroviral expression of GOLGA4-JAK2 in murine pro-B cells, factor-independent growth, STAT phosphorylation, and JAK inhibitor sensitivity

    PMID:34697799

    Open questions at the time
    • Contribution of the GOLGA4 coiled-coil to fusion dimerization not directly dissected
    • Single lab
  10. 2019 Low

    Demonstrated a parallel oncogenic fusion, GOLGA4-RAF1, correlating with constitutive ERK activation in melanoma and broadening GOLGA4's repertoire as a kinase fusion partner.

    Evidence Whole-genome and transcriptome sequencing, IHC for pERK/ETV5/Ki67, and clinical MEK inhibitor response in a single case

    PMID:30835257

    Open questions at the time
    • Single case with correlative data only; no in vitro reconstitution of fusion kinase activity
    • Mechanism of RAF1 dimerization via the fusion not tested
  11. 2025 Medium

    Provided structural context by placing GOLGA4 in a discrete layer at the Golgi rim and showing golgins self-assemble into anti-parallel dimeric filaments, supporting a scaffolding role.

    Evidence 3D super-resolution microscopy (10-20 nm) and in vitro dimerization/filament-assembly assays on isolated golgins (preprint)

    Open questions at the time
    • Preprint, not yet peer-reviewed
    • Functional consequence of filament assembly for vesicle capture not established
    • How the rim localization relates to vesicle tethering unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • How GOLGA4 mechanistically couples Arl1-dependent TGN recruitment, selective vesicle capture, and MACF1-mediated cytoskeletal transport into a single export pathway remains unresolved.
  • No structure of GOLGA4 bound to cargo or vesicle
  • Direct tethering activity not reconstituted
  • Integration of golgin filament assembly with cargo sorting unknown

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0060090 molecular adaptor activity 2 GO:0005198 structural molecule activity 1 GO:0008092 cytoskeletal protein binding 1
Localization
GO:0005794 Golgi apparatus 3 GO:0005829 cytosol 2 GO:0031410 cytoplasmic vesicle 1
Pathway
R-HSA-1643685 Disease 2 R-HSA-5653656 Vesicle-mediated transport 2 R-HSA-9609507 Protein localization 2 R-HSA-168256 Immune System 1 R-HSA-9612973 Autophagy 1
Partners

Evidence

Reading pass · 13 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1995 Golgin-245 (GOLGA4) was identified as a 245 kDa Golgi complex autoantigen containing extensive coiled-coil domains and a granin signature motif (ESLALEELEL), establishing it as the first cytosolic Golgi protein bearing structural similarities to the granin family. cDNA cloning from HeLa library using anti-Golgi autoimmune serum, immunoprecipitation, Western blot, in vitro translation, RACE The Journal of biological chemistry Medium 8537393
1996 p230 (GOLGA4) was molecularly cloned and characterized as a peripheral membrane protein localized to the cytosolic face of the trans-Golgi, with extensive heptad repeats forming coiled-coil structures and a granin motif; its gene was mapped to chromosome 6p12-22; two alternatively spliced mRNAs were detected. cDNA cloning from HeLa library using autoantibodies, sequence analysis, chromosomal mapping, Northern blot The Journal of biological chemistry Medium 8626529
1996 p230 (GOLGA4) is localized on the trans-Golgi network (TGN) and associates with non-clathrin-coated vesicles budding from TGN membranes; GTP-gamma-S or AlF4- treatment causes accumulation of p230 on Golgi membranes, indicating G protein-regulated cycling between cytosol and TGN buds/vesicles; p230-labeled vesicles are distinct from clathrin-coated vesicles and from p200-labeled vesicles. Immunogold labeling of HeLa cell cryosections, streptolysin-O permeabilization, AlF4- treatment of isolated Golgi membranes, dual immunogold labeling Journal of cell science High 9013329
1999 The C-terminal 98 amino acid domain of p230 (GOLGA4) is necessary and sufficient for Golgi targeting; a minimum 42-amino-acid stretch within this C-terminal domain is essential for Golgi localization; the domain competes with endogenous p230 for membrane binding sites; Golgi binding of the C-terminal domain is brefeldin A-sensitive and G protein-regulated. Transfection of COS cells with GFP-tagged deletion mutants and alanine scanning mutagenesis, fluorescence microscopy Journal of cell science High 10318758
2004 The N-terminal domain of p230 (GOLGA4) directly interacts with the C-terminal domain of MACF1 (a microtubule-actin crosslinking protein); this interaction is required for transport of GPI-anchored proteins (but not transmembrane proteins like VSVG) from the TGN to the cell periphery. Yeast two-hybrid screening, co-immunoprecipitation, in vitro binding assay, double immunofluorescence, dominant-negative FLAG-tagged construct expression in HeLa cells, YFP-SP-GPI trafficking assay Experimental cell research High 15265687
2005 Active Arl1 GTPase (GTP-bound form) interacts directly with the GRIP domain in the C-terminus of Golgin-245 (GOLGA4), mediating TGN recruitment of the protein. GST pull-down assay — GST-Arl1(GTP) recovered endogenous Golgin-245 from HeLa cell cytosol; GST-GRIP domain retained endogenous active Arl1 Methods in enzymology Medium 16413289
2008 p230/golgin-245 (GOLGA4) physically interacts with CD99 in the TGN and regulates HLA class I surface expression; overexpression of the GRIP domain of p230 leads to surface and intracellular downmodulation of HLA class I molecules, placing p230 in the pathway of HLA class I trafficking from TGN to cell surface. Co-immunoprecipitation, IFN-gamma stimulation, dominant-negative GRIP domain overexpression, flow cytometry for HLA class I surface levels Blood Medium 18849489
2000 A novel amino-terminal splice variant of p230 (GOLGA4) exists with an alternative splicing within the first proline-rich domain; this splice variant is more frequent than the originally reported sequence and also localizes to the TGN. Autoimmune serum-based cDNA library screening, RT-PCR analysis, immunofluorescence, immunoblot, GST-fusion protein reactivity European journal of cell biology Medium 11139141
2014 p230/golgin-245 (GOLGA4) and its binding partner MACF1 are required for phagophore formation during amino acid starvation-induced autophagy; p230 or MACF1 knockdown impairs mAtg9 recruitment to peripheral phagophores from the TGN, blocking autophagosome formation; p230 itself is detected in autophagosomes/autolysosomes during autophagosome biogenesis. siRNA knockdown of p230 and MACF1 in HeLa cells, LC3 puncta quantification, mAtg9 trafficking assay, dominant-negative MACF1 domain overexpression, autophagic flux measurement Biochemical and biophysical research communications Medium 25436429
2020 GOLGA4 (golgin-245) global knockout in mice produced fertile males with normal testis morphology, normal sperm, and normal testicular histology, demonstrating that GOLGA4 is dispensable for mouse spermatogenesis despite high expression in testes. CRISPR/Cas9 global knockout mouse, fertility testing, testicular histology, sperm morphology analysis Biochemical and biophysical research communications Medium 32736686
2021 A GOLGA4-JAK2 fusion gene drives constitutive JAK/STAT signaling activation and factor-independent growth in B-cell precursors, establishing GOLGA4 as a fusion partner that can aberrantly activate JAK2 kinase signaling in B-cell ALL. mRNA sequencing to identify fusion, retroviral expression of GOLGA4-JAK2 in murine pro-B cells, factor-independent growth assay, Western blot for STAT phosphorylation, JAK inhibitor sensitivity assay British journal of haematology Medium 34697799
2019 A GOLGA4-RAF1 chromosomal fusion results in constitutive ERK activation and elevated ETV5 expression in melanoma, establishing GOLGA4 as a fusion partner capable of activating the RAF1-MEK-ERK pathway. Whole-genome sequencing and transcriptome analysis, immunohistochemistry for ERK activation markers (pERK, ETV5, Ki67), clinical MEK inhibitor response The Journal of clinical investigation Low 30835257
2025 Using 3D super-resolution microscopy, GOLGA4 (golgin-245) was localized to one of four discrete layers at the rim of the Golgi apparatus (not inside the stack between cisternae); biochemically, golgin proteins including GOLGA4 form anti-parallel dimers and self-assemble into multi-micron-long filamentous bands, supporting a structural role at the Golgi rim. 3D super-resolution microscopy (10-20 nm resolution), biochemical characterization of isolated golgin proteins (dimerization and filament assembly assays) bioRxivpreprint Medium

Source papers

Stage 0 corpus · 34 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
1999 The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. The Journal of experimental medicine 409 10224280
1995 Molecular characterization of Golgin-245, a novel Golgi complex protein containing a granin signature. The Journal of biological chemistry 97 8537393
1983 Immunolocalization of a novel, cytoskeleton-associated polypeptide of Mr 230,000 daltons (p230). The Journal of cell biology 87 6339521
1996 Molecular characterization of trans-Golgi p230. A human peripheral membrane protein encoded by a gene on chromosome 6p12-22 contains extensive coiled-coil alpha-helical domains and a granin motif. The Journal of biological chemistry 82 8626529
1996 p230 is associated with vesicles budding from the trans-Golgi network. Journal of cell science 75 9013329
1983 The p36 substrate of tyrosine-specific protein kinases co-localizes with non-erythrocyte alpha-spectrin antigen, p230, in surface lamina of cultured fibroblasts. The EMBO journal 72 6357780
1995 Establishment and molecular characterization of a novel leukemic cell line with Philadelphia chromosome expressing p230 BCR/ABL fusion protein. Cancer research 71 7606740
1999 The Golgi-targeting sequence of the peripheral membrane protein p230. Journal of cell science 65 10318758
2004 Interaction between p230 and MACF1 is associated with transport of a glycosyl phosphatidyl inositol-anchored protein from the Golgi to the cell periphery. Experimental cell research 64 15265687
2002 Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. Cancer 53 12015767
2019 Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion. The Journal of clinical investigation 45 30835257
2002 BCR/ABL p210, p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML). Clinical and laboratory haematology 43 12067277
2008 Regulation of HLA class I surface expression requires CD99 and p230/golgin-245 interaction. Blood 42 18849489
2000 Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. Blood 41 10779439
2003 The phosphotriesterase gene opdA in Agrobacterium radiobacter P230 is transposable. FEMS microbiology letters 38 12757939
1998 P230 BCR/ABL protein may be associated with an acute leukaemia phenotype. British journal of haematology 38 9886327
2018 The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission. Scientific reports 32 30297725
2014 Trans-Golgi protein p230/golgin-245 is involved in phagophore formation. Biochemical and biophysical research communications 20 25436429
2003 Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis. Blood 15 12623846
2024 Preclinical evaluation of a novel CAR-T therapy utilizing a scFv antibody highly specific to MAGE-A4p230-239/HLA-A∗02:01 complex. Molecular therapy : the journal of the American Society of Gene Therapy 12 38243600
2000 Novel variant of p230 trans-Golgi network protein identified by serum from Sjögren's syndrome patient. European journal of cell biology 11 11139141
2020 GOLGA4, A Golgi matrix protein, is dispensable for spermatogenesis and male fertility in mice. Biochemical and biophysical research communications 10 32736686
2005 Interaction of Arl1 GTPase with the GRIP domain of Golgin-245 as assessed by GST (glutathione-S-transferase) pull-down experiments. Methods in enzymology 10 16413289
2005 Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl. Gene therapy 6 15616602
2002 Characterization of mouse tGolgin-1 (golgin-245/trans-golgi p230/256 kD golgin) and its upregulation during oligodendrocyte development. DNA and cell biology 6 12162805
2021 Identification of a novel GOLGA4-JAK2 fusion gene in B-cell acute lymphoblastic leukaemia. British journal of haematology 5 34697799
2013 Early Complete Molecular Response to First-Line Nilotinib in Two Patients with Chronic Myeloid Leukemia Carrying the p230 Transcript. Case reports in hematology 5 23956893
2006 Oral administration of imatinib to P230 BCR/ABL-expressing transgenic mice changes clones with high BCR/ABL complementary DNA expression into those with low expression. International journal of hematology 4 17118762
2023 De nove Philadelphia chromosome-positive myelodysplastic syndromes with complex karyotype and p230 BCR::ABL fusion transcript: a case report with a literature review. Hematology (Amsterdam, Netherlands) 2 37288817
2021 [Clinical Effect of Tyrosine Kinase Inhibitors in the Treatment of P230 Chronic Myeloid Leukemia]. Zhongguo shi yan xue ye xue za zhi 1 34893105
2025 Philadelphia chromosome-positive de novo myelodysplastic syndrome with the p230 BCR::ABL1 fusion gene: a case report. International journal of hematology 0 41148513
2025 Inferior Outcomes of p230-CML with Imatinib: a Report of 2 Cases of p210/p230 Co-Expressed CML Showing Rapid Progression To Leukaemia Cutis along with the Systematic Review. Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 0 42040683
2019 Author Correction: The Plasmodium falciparum male gametocyte protein P230p, a paralog of P230, is vital for ookinete formation and mosquito transmission. Scientific reports 0 31053746
1997 Isolation and characterization of a 230 kDa protein (p230) specifically expressed in fetal brains: its involvement in neurite outgrowth from rat cerebral cortex neurons grown on monolayer of astrocytes. Journal of biochemistry 0 9498558

Missed literature

Know a paper Affinage missed for GOLGA4? Flag it for the maintainers and the community.

No submissions yet.